These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38390973)

  • 1. Establishment of a Pilot Newborn Screening Program for Spinal Muscular Atrophy in Saint Petersburg.
    Kiselev A; Maretina M; Shtykalova S; Al-Hilal H; Maslyanyuk N; Plokhih M; Serebryakova E; Frolova M; Shved N; Krylova N; Il'ina A; Freund S; Osinovskaya N; Sultanov I; Egorova A; Lobenskaya A; Koroteev A; Sosnina I; Gorelik Y; Bespalova O; Baranov V; Kogan I; Glotov A
    Int J Neonatal Screen; 2024 Jan; 10(1):. PubMed ID: 38390973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of Spinal Muscular Atrophy Based on the Results of a Large-Scale Pilot Project on 202,908 Newborns.
    Efimova IY; Zinchenko RA; Marakhonov AV; Balinova NV; Mikhalchuk KA; Shchagina OA; Polyakov AV; Mudaeva DA; Saydaeva DH; Matulevich SA; Parshintseva PD; Belyashova EY; Yakubovskiy GI; Tebieva IS; Gabisova YV; Irinina NA; Jamschikova AV; Nurgalieva LR; Saifullina EV; Nevmerzhitskaya KS; Belyaeva TI; Romanova OS; Voronin SV; Kutsev SI
    Pediatr Neurol; 2024 Jul; 156():147-154. PubMed ID: 38781723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PCR-Based Screening of Spinal Muscular Atrophy for Newborn Infants in Hyogo Prefecture, Japan.
    Noguchi Y; Bo R; Nishio H; Matsumoto H; Matsui K; Yano Y; Sugawara M; Ueda G; Wijaya YOS; Niba ETE; Shinohara M; Bouike Y; Takeuchi A; Okamoto K; Saito T; Shimomura H; Lee T; Takeshima Y; Iijima K; Nozu K; Awano H
    Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36421785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newborn screening for spinal muscular atrophy: The Wisconsin first year experience.
    Baker MW; Mochal ST; Dawe SJ; Wiberley-Bradford AE; Cogley MF; Zeitler BR; Piro ZD; Harmelink MM; Kwon JM
    Neuromuscul Disord; 2022 Feb; 32(2):135-141. PubMed ID: 35120759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot Study on Newborn Screening for Spinal Muscular Atrophy.
    Fonseca H; Ribeiro D; Guimarães F; Pinto C; Marcão A; Sousa C; Carvalho I; Lopes L; Rodrigues D; Rocha H; Vilarinho L
    Endocr Metab Immune Disord Drug Targets; 2023 Sep; ():. PubMed ID: 37711122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presymptomatic Diagnosis of Spinal Muscular Atrophy Through Newborn Screening.
    Chien YH; Chiang SC; Weng WC; Lee NC; Lin CJ; Hsieh WS; Lee WT; Jong YJ; Ko TM; Hwu WL
    J Pediatr; 2017 Nov; 190():124-129.e1. PubMed ID: 28711173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiplex Droplet Digital PCR Method Applicable to Newborn Screening, Carrier Status, and Assessment of Spinal Muscular Atrophy.
    Vidal-Folch N; Gavrilov D; Raymond K; Rinaldo P; Tortorelli S; Matern D; Oglesbee D
    Clin Chem; 2018 Dec; 64(12):1753-1761. PubMed ID: 30352867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilot Program of Newborn Screening for 5q Spinal Muscular Atrophy in the Russian Federation.
    Mikhalchuk K; Shchagina O; Chukhrova A; Zabnenkova V; Chausova P; Ryadninskaya N; Vlodavets D; Kutsev SI; Polyakov A
    Int J Neonatal Screen; 2023 May; 9(2):. PubMed ID: 37218894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of a Fast, Robust, Inexpensive, Two-Tiered Neonatal Screening Test algorithm on Dried Blood Spots for Spinal Muscular Atrophy.
    Strunk A; Abbes A; Stuitje AR; Hettinga C; Sepers EM; Snetselaar R; Schouten J; Asselman FL; Cuppen I; Lemmink H; van der Pol WL; Engel H
    Int J Neonatal Screen; 2019 Jun; 5(2):21. PubMed ID: 33072980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic screening of spinal muscular atrophy using a real-time modified COP-PCR technique with dried blood-spot DNA.
    Ar Rochmah M; Harahap NIF; Niba ETE; Nakanishi K; Awano H; Morioka I; Iijima K; Saito T; Saito K; Lai PS; Takeshima Y; Takeuchi A; Bouike Y; Okamoto M; Nishio H; Shinohara M
    Brain Dev; 2017 Oct; 39(9):774-782. PubMed ID: 28522225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Spinal Muscular Atrophy Carrier Status by Determining
    Wijaya YOS; Purevsuren J; Harahap NIF; Niba ETE; Bouike Y; Nurputra DK; Rochmah MA; Thursina C; Hapsara S; Yamaguchi S; Nishio H; Shinohara M
    Int J Neonatal Screen; 2020 Jun; 6(2):43. PubMed ID: 33073034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Carrier Frequency of Two
    Davidson JE; Russell JS; Martinez NN; Mowat DR; Jones KJ; Kirk EP; Kariyawasam D; Farrar M; D'Silva A
    Genes (Basel); 2023 Jul; 14(7):. PubMed ID: 37510307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infants Diagnosed with Spinal Muscular Atrophy and 4 SMN2 Copies through Newborn Screening - Opportunity or Burden?
    Müller-Felber W; Vill K; Schwartz O; Gläser D; Nennstiel U; Wirth B; Burggraf S; Röschinger W; Becker M; Durner J; Eggermann K; Müller C; Hannibal I; Olgemöller B; Schara U; Blaschek A; Kölbel H
    J Neuromuscul Dis; 2020; 7(2):109-117. PubMed ID: 32144995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinal Muscular Atrophy: Advanced Version of Screening System with Real-Time mCOP-PCR and PCR-RFLP for SMN1 Deletion.
    Niba ETE; Rochmah MA; Harahap NIF; Awano H; Morioka I; Iijima K; Takeshima Y; Saito T; Saito K; Takeuchi A; Lai PS; Bouike Y; Matsuo M; Nishio H; Shinohara M
    Kobe J Med Sci; 2019 Jul; 65(2):E49-E53. PubMed ID: 31956256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spinal muscular atrophy carriers with two SMN1 copies.
    Ar Rochmah M; Awano H; Awaya T; Harahap NIF; Morisada N; Bouike Y; Saito T; Kubo Y; Saito K; Lai PS; Morioka I; Iijima K; Nishio H; Shinohara M
    Brain Dev; 2017 Nov; 39(10):851-860. PubMed ID: 28676237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alberta Spinal Muscular Atrophy Newborn Screening-Results from Year 1 Pilot Project.
    Niri F; Nicholls J; Baptista Wyatt K; Walker C; Price T; Kelln R; Hume S; Parboosingh J; Lilley M; Kolski H; Ridsdale R; Muranyi A; Mah JK; Bulman DE
    Int J Neonatal Screen; 2023 Jul; 9(3):. PubMed ID: 37606479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postnatal management of preterm infants with spinal muscular atrophy: experience from German newborn screening.
    Trollmann R; Johannsen J; Vill K; Köhler C; Hahn A; Illsinger S; Pechmann A; Hagen MV; Müller-Felber W
    Orphanet J Rare Dis; 2024 Sep; 19(1):353. PubMed ID: 39327607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between the SMN2 gene copy number and clinical characteristics of patients with spinal muscular atrophy with homozygous deletion of exon 7 of the SMN1 gene.
    Zarkov M; Stojadinović A; Sekulić S; Barjaktarović I; Perić S; Keković G; Drasković B; Stević Z
    Vojnosanit Pregl; 2015 Oct; 72(10):859-63. PubMed ID: 26665550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newborn screening for spinal muscular atrophy in Germany: clinical results after 2 years.
    Vill K; Schwartz O; Blaschek A; Gläser D; Nennstiel U; Wirth B; Burggraf S; Röschinger W; Becker M; Czibere L; Durner J; Eggermann K; Olgemöller B; Harms E; Schara U; Kölbel H; Müller-Felber W
    Orphanet J Rare Dis; 2021 Mar; 16(1):153. PubMed ID: 33789695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of population-based newborn screening reveals low incidence of spinal muscular atrophy.
    Kay DM; Stevens CF; Parker A; Saavedra-Matiz CA; Sack V; Chung WK; Chiriboga CA; Engelstad K; Laureta E; Farooq O; Ciafaloni E; Lee BH; Malek S; Treidler S; Anziska Y; Delfiner L; Sakonju A; Caggana M
    Genet Med; 2020 Aug; 22(8):1296-1302. PubMed ID: 32418989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.